INAB · CIK 0001740279 · FY2025 live · 2025-12-31
IN8BIO, INC.
View as
Model
Classic Z
FY2025
−3.69
Zone
Distress
Prior
—
Market DD
—
1y PD
—
−3.69
Z″ −7.15
Score −3.69 · distress below 1.80, grey to 2.99, safe at 3.00 and above.
Classic Z factor contributions
X1 Working capital / assets
Short-term liquidity versus the size of the balance sheet.
0.771.2 × = 0.92X2 Retained earnings / assets
Cushion from years of profits. Share buybacks can push this negative at otherwise healthy firms.
−4.371.4 × = −6.12X3 EBIT / assets
Operating return on assets. Highest weight in the original model.
−0.603.3 × = −1.99X4 Book equity / liabilities
Book equity versus the liability stack. Mega-caps often look greyer here than they would if X4 used market cap.
5.830.6 × = 3.50X5 Sales / assets
Asset turnover — how much revenue the asset base supports.
0.001 × = 0.00
Five-year path
Need two annual 10-Ks to draw a path. The desk will pull this issuer’s filings rather than invent a series.
Meridian Rank
17.82
0–100 · Classic Z tape · not a PD
Book standing
20
Year change
—
Market PD
—
O-score
12
Events on this name
Same published rows as Today. Not a live recompute.
Market PD unavailable
watch · 41
Overview
rule-v1
IN8BIO, INC. is on classic Z at −3.69 (distress) for FY2025, from an SEC 10-K. Retained earnings / assets is the line that sets the print; book equity / liabilities is the runner-up. This is the first live year on the desk. No market tape loaded. Classic Z was fit on manufacturers; buybacks can send retained earnings negative at otherwise healthy issuers, and X4 is book equity, not market cap.
Book screen Distress; market PD —. Tape not priced — not a single default call.
Market DD · naive Merton
No market tape yet.
Pull a year of closes (Yahoo, Nasdaq if Yahoo is limited) and size equity from Nasdaq cap or EDGAR shares. Distance-to-default and 1-year PD stay blank until then.
Sector peers
Closest Classic Z scores · 36th percentile in Healthcare.
KPI widgets
Current assets
$28M
Total assets
$32M
Current liabilities
$3M
Total liabilities
$5M
Working capital
$25M
Retained earnings
−$141M
EBIT
−$19M
Total sales
$0
Book equity
$28M
Accession 0001193125-26-104181. Live rank is the latest 10-K on EDGAR (FY2025, period 2025-12-31). Classic Z is the live score. View as does not rewrite the live rank. X4 is book equity. Pulled 13 Sept 2026.